Summary
The positive inotropic effect of the alpha1-adrenoceptor agonist phenylephrine is accompanied by an increase in the presumed second messengers inositol 1,4,5-trisphosphate (1,4,5-IP3) and inositol 1,3,4,5-tetrakisphosphate (1,3,4,5-IP4). Both 1,4,5-IP3 and 1,3,4,5-IP4 sensitize myocardial contractile proteins in chemically skinned fibers. In addition to the Ca++ releasing effect of 1,4,5-IP3 from the sarcoplasmic reticulum the Ca++-sensitizing effect of the inositol phosphates may play a role in alpha1-adrenergic positive inotropism. In isolated heart muscle preparations from patients with endstage heart failure (due to dilated cardiomyopathy) beta-adrenergic as well as alpha1-adrenergic effects are reduced compared to preparations from healthy hearts. The reduced beta-adrenergic effects can in part be explained by an increased content of signal transducing G1-proteins. It is tempting to investigate whether other G proteins are also altered in severe congestive heart failure.
Similar content being viewed by others
References
Aass H, Skomedal T, Osnes JB (1983) Demonstration of an alpha-adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle. J Pharmacol Exp Ther 226:572–578
Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315–321
Blinks JR, Endoh M (1986) Modification of myofibrillar responsiveness to Ca++ as an inotropic mechanism. Circulation 73 (suppl III):III-85–III-98
Böhm M, Diet F, Feiler G, Kemkes B, Erdmann E (1988)α-adrenoceptors andα-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357–364
Böhm M, Schmitz W, Scholz H (1987) Evidence against a role of a pertussis toxin-sensitive guanine nucleotide-binding protein in the alpha1-adrenoceptor-mediated positive inotropic effect in the heart. Naunyn Schmiedebergs Arch Pharmacol 335:476–479
Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB (1986)β 1- andβ 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptors subtypes to muscle contraction and selectiveβ 1-receptor down-regulation in heart failure. Circulation. 59:297–309
Brodde OE, Schüler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R, Reidemeister C, Warnecke H, Zerkowski HR (1986) J Cardiovasc Pharmacol 8:1235–1242
Brückner R, Scholz H (1984) Effects ofα-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart. Br J Pharmacol 82:223–232
Brückner R, Meyer W, Mügge A, Schmitz W, Scholz H (1984)α-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur J Pharmacol 99:345–347
Brückner R, Mügge A, Scholz H (1985) Existence and functional role of alpha1-adrenoceptors in the mammalian heart. J Mol Cell Cardiol 17:639–645
Burgess GM, Godfrey PP, McKinney JS, Berridge MJ, Irvine RF, Putney JW (1984) The second messenger linking receptor activation to internal Ca release in liver. Nature 309:63–66
Dawson AP, Irvine RF (1984) Inositol (1,4,5)-trisphosphate promoted Ca2+ release from microsomal fractions of rat liver. Biochem Biophys Res Commun 120:858–864
Endoh M, Blinks JR (1988) Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: Reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors. Circ Res 62:247–265
Fabiato A (1986) Inositol (1,4,5)-trisphosphate-induced release of Ca++ from the sarcoplasmic reticulum of skinned cardiac cells. Biophys J 49:190a
Feldmann MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331
Freund P, Müller-Beckmann B, Strein K, Kling L, Rüegg JC (1987) Ca2+-sensitizing effect of BM 14.478 on skinned cardiac muscle fibres of guinea-pig papillary muscle. Eur J Pharmacol 136:243–246
Herzig JW, Feile K, Rüegg CJ (1981) Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle. Drug Res 31:188–191
Hirata M, Suematsu E, Hashimoto T, Hamachi T, Koga T (1984) Release of Ca++ from a nonmitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate. Biochem J 223:229–236
Irvine RF, Moor RM (1986) Microinjection of inositol 1,3,4,5-tetrakisphosphate activates seaurchin eggs by a mechanism dependent on external Ca2+. Biochem J 240:917
Irvine RF, Anggard EE, Letcher AJ, Downes CP (1985) Metabolism of inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate in rat parotid glands. Biochem J 229:505–511
Joseph SK, Thomas AP, Williams RJ, Irvine RF, Williamson JR (1984) Myo-inositol 1,4,5-trisphosphate. A second messenger for the hormonal mobilization of intracellular Ca2+ in liver. J Biol Chem 259:3077–3081
Kohl C, Schmitz W, Scholz H, Scholz J, Tóth M, Döring V, Kalmár P (1988) Evidence for alpha1-adrenoceptor-mediated increase of inositol trisphosphate in the human heart. J Cardiovasc Pharmacol: in press
Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Scholz J, Starbatty J, Steinkraus V, Döring V, Kalmár P, Rödiger W, Klöppel G, Hanrath P (1988) Inotropic response in CHF: myocarditis vs dilated cardiomyopathy. Am Heart J 115:1346–1348
Morris AP, Gallacher DV, Irvine RF, Petersen OH (1987) Synergism of inositol trisphosphate and tetrakisphosphate in activating Ca2+ dependent K+ channels. Nature 330:653–655
Movsesian MA, Thomas AP, Selak M, Williamson JR (1985) Inositol trisphosphate does not release Ca2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum. FEBS Lett 185:328–332
Neumann J, Schmitz W, Scholz H, von Meyerinck L, Döring V, Kalmár P (1988) Increase of myocardial Gi-proteins in human heart failure. Lancet: in press
Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science (Wash. DC) 233:305–312
Nosek TM, Williams MF, Zeigler ST, Godt RE (1986) Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am J Physiol 250:C807-C811
Poggioli J, Sulpice JC, Vassort G (1986) Inositol phosphate production following alpha1-adrenergic, muscarinic or electrical stimulation in isolated rat hearts. FEBS Lett 206:292–298
Renard D, Poggioli J (1987) Does the inositol tris/tetrakisphosphate pathway exist in rat heart? FEBS Lett 217:117–123
Rüegg JC, Pfitzer G, Eubler D, Zeugner C (1984) Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-(2-(4-methodyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone. Drug Res 34:1736–1738
Scherrer NM, Ferguson JE (1985) Inositol 1,4,5-trisphosphate is not effective in releasing calcium from skeletal sarcoplasmic reticulum microsomes. Biochem Biophys Res Commun 128:1064–1070
Schmitz W, Scholz H, Scholz J, Steinfarth M (1987) Increase in IP3 precedes alpha-adrenoceptor-induced increase in force of contraction in cardicac muscle. Eur J Pharmacol 140:109–111
Schmitz W, Scholz H, Scholz J, Steinfath M, Lohse M, Puurunen J, Schwabe U (1987) Pertussis toxin does not inhibit the alpha1-adrenoceptor-mediated effect on inositol phosphate production in the heart. Eur J Pharmacol 134:377–378
Schmitz W, Scholz H, Erdmann E (1987) Effects ofα andβ-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human heart muscle preparations. TIPS 8:447–450
Scholz H (1980) Effects of beta- and alpha-adrenoceptor activators and adrenergic transmitter releasing agents on the mechanical activity in the heart. In: Szekeres L (ed) Adrenergic activators and inhibitors, Handbook of experimental pharmacology; Springer, Heidelberg, Vol. 54/I, 651–733
Scholz J, Schaefer B, Schmitz W, Scholz H, Steinfath M, Lohse M, Schwabe U, Puurunen J (1988) Alpha1-adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. J Pharmacol Exp Ther 245:327–335
Schümann HJ, Wagner J, Knorr A, Reidemeister JC, Sadony V, Schramm G (1978) Demonstration in human atrial preparations ofα-adrenoceptors mediating positive inotropic effects. Naunyn Schmiedebergs Arch Pharmacol 302:333–336
Streb H, Irvine RF, Berridge MJ, Schulz I: Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic cells by inositol-1,4,5-trisphosphate. Nature 306:67–69
Thieleczek R, Heilmeyer LMG Jr (1986) Inositol 1,4,5-trisphosphate enhances Ca2+-sensitivity of the contractile mechanism of chemically skinned rabbit skeletal muscle fibres. Biochem Biophys Res Commun 135:662–669
Vergara J, Tsien RY, Delay M (1985) Inositol 1,4,5-trisphosphate: A possible chemical link in excitation-contraction coupling in muscle. Proc Natl Acad Sci 82:6352–6356
Volpe P, Salviati G, Di Virgilio F, Pozzan T (1985) Inositol 1,4,5-trisphosphate induces calcium release from sarcoplasmic reticulum of skeletal muscle. Nature 316:347–349
Woodcock EA, Schmank White LB, Smith A, Mc Leòd JK (1987) Stimulation of phosphatidylinositol metabolism in the isolated, perfused rat heart. Circ Res 61:625–631
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitz, W., Kohl, C., Neumann, J. et al. On the mechanism of positive inotropic effects of alpha-adrenoceptor agonists. Basic Res Cardiol 84, 23–33 (1989). https://doi.org/10.1007/BF02650344
Issue Date:
DOI: https://doi.org/10.1007/BF02650344